WISE Closes €30M Series D to Advance Heron Lead for Spinal Cord Stimulation
WISE has announced the closing of an oversubscribed Series D financing round totaling €30 million, with ENEA Tech and Biomedical joining as a strategic investor, to advance the Heron lead for spinal cord stimulation through regulatory certification and first-in-human studies.
更多内容
